We have analysed, with the aid of a novel radioiodinated oxytocin (OT)-receptor antagonist, the role of Mg2" in uterine OT-receptor function. The antagonist-receptor interaction was characterized by high affinity, reversibility and stereospecificity in Tris/HCl buffer containing 3 mmol of Mg2+/litre as well as buffer free of Mg2". By contrast, omission of Mg2" decreased the affinity of the receptor for OT by about 1500-fold; moreover, the stereospecificity of agonist, but not antagonist, binding was lost. Since guanine nucleotides had relatively minor effects in this system ( < 2-fold decrease in OT affinity), we suggest that the agonist-binding site of OT receptors is directly modulated by Mg2", unlike other receptors, where the effects of bivalent cations are exerted via guanine-nucleotide-binding (G-) proteins. Thus the ligand recognition mechanism of OT receptors may be novel in this respect.
INTRODUCTION
Oxytocin (OT), like other peptide hormones, exerts its cellular actions by interacting with specific high-affinity receptors on the surface of target cells in various organs of the body. Previous studies have demonstrated that OT is bound by its receptor only in the presence of Mg2" or related cations, which were postulated to modulate the affinity, as well as the availability, of the receptors for interaction with the ligand (cf. [1, 2] [3] . In the present study we have used such a novel OT analogue to examine the role of Mg2" in the recognition of ligands by the OT receptor in rat uterus.
MATERIALS AND METHODS
Female Wistar rats (200-300 g body wt.; Harlan Olac, Bicester, Oxon., U.K.) were used. Unless indicated otherwise, the animals received subcutaneous implants made of silastic tubing which contained 50 mg of diethylstilboestrol (Sigma, Poole, Dorset, U.K.) [5] [6] days before they were killed by decapitation. A crude membrane fraction of uteri was prepared as described previously [4, 5] . The final pellet was resuspended in Tris/HCl (0.05 mol/l), pH 7.4, containing bacitracin and bovine serum albumin [0.01 and 0.1 % (w/v) respectively; from Sigma], EGTA (1 mmol/l) and various concentrations of bivalent cations (Mg2" as MgSO4, the others as chlorides) or Na2EDTA (2.5 mmol/l). The concentration of protein in the binding assay was 60 ,ug/ml (Coomassie Brilliant Blue method [6] ). The reaction was at room temperature for 60 min unless otherwise indicated; separation was performed by vacuum filtration over GF/C filters (Whatman) [4, 5] . The [3, 9] . The specific radioactivity of the '25l-OTA obtained was estimated to be 0.6 nCi/fmol [10] .
Ligand-displacement curves were linearized by logitlog transformation, the IC50 value was estimated by linear-regression analysis, and the inhibitor constant (K1) was calculated [11] . All (Fig. 1) . Estimation of the 'on-' and 'off-' rates [12] These findings indicate that, in the presence of EDTA, 125I-OTA labels physiologically relevant oxytocin receptors in the uterus membrane suspension (cf. [1] [2] [3] [4] (Fig. 2) .
In summary, Mg2+, Mn2+ and Co2+ are all effective in promoting the interaction of OT with the receptor labelled with antagonist, whereas Ca2+ is ineffective. This is also the case when [3H] OT is the tracer, and has been also reported for vasopressin isoreceptors (cf. [1, 13, 14, 16] ).
The potency of several oxytocin analogues to compete for OT receptors with 125I-OTA was estimated in both the presence and absence of Mg2" (Table 1 ). The cation did not affect the K1 of any of the antagonists compounds tested. In marked contrast, in Mg2"-free buffer, the agonists OT and TG-OT were more than 1000-fold less potent than in Mg2" at 1 mmol/l (Table 1) . However, both peptides completely displaced the tracer at high concentrations (up to 10-4 mol/l), along curves that were parallel with those for the respective peptides in Mg2+-containing medium, indicating that all sites labelled with 125I-OTA are available for interaction with OT and TG-OT. The extent of the right-shift was not the same for all agonists: it was proportional to the potency of the compound in Mg2+-containing buffer. Thus, AVP and the partial-agonist peptide [D-Tyr-2]OT [15] became virtually equipotent with OT, the range of relative potencies being markedly narrowed from 2300-fold to 2.3-fold.
Given the striking change in specificity, we tested three oligopeptides, namely bradykinin, somatostatin and Saralasin in the binding assay. In the presence of Mg2+ we found all peptides to be at least 10000-fold less potent than OT. However, in Mg2+-free buffer, somatostatin and bradykinin displaced 125I-OTA only 48-and 279-fold less potently than OT respectively, and this was largely due to the decrease in the potency of OT. Saralasin was ineffective up to 1 mmol/l. Thus, while there is a marked decrease in the specificity of ligand recognition in Mg2+-free medium, preference for some traits of the oxytocinergic stereochemistry is still apparent.
Agonist-specific modulation of receptor affinity by Mg2+ has been shown previously in other receptor systems (cf. [18, 19] ), but the degree of the change found in the present study is unprecedented. Furthermore, no systematic studies of specificity have been reported for the lowaffinity state of the receptors under study. Our data indicate that Mg2+ is involved in stabilizing a highaffinity high-specificity conformation of the receptor, which is necessary for the binding of agonists. In contrast, antagonists are not affected, possibly because they stabilize another conformation of the receptor that is not capable of signal transduction. This notion is supported by previous findings showing that different structural features are required for the high-affinity binding of antagonists than for agonists (cf. [8,8a] ).
A decrease in receptor affinity and specificity for agonists with no change in the binding of antagonists can be brought about in the presence of Mg2' by genetic engineering of ,-adrenergic receptors [17] . Thus, in at least two different ligand-receptor systems, agonist affinity and specificity change in parallel, while the binding of antagonists is unaffected. The molecular mechanisms underlying this phenomenon remain to be explored.
Are the effects of Mg2+ on agonist affinity mediated via G-proteins?
Since most receptor-ligand interactions are modulated by Mg21 in association with G-proteins (cf. [18, 19] ), the effects of Mg2+ were examined in the presence of the GMP analogue guanosine 5'-[fly-imido]triphosphate (p[NH]ppG; 'GMP-PNP') at a concentration of 10-4 mol/l, which is maximally effective in most systems [18, 19] . As shown in Fig. 2 Further experiments indicated that, at 1 mmol of Mg2"/l, p[NH]ppG causes an apparent 1.3-2-fold decrease (right-shift) in the potency of OT to displace 125I-OTA (Fig. 2, inset) . Because of the small change caused by the guanine nucleotide, we cannot say with certainty whether all or only some receptor sites were in the low-affinity state.
The amount of 125I-OTA bound was not altered by p[NH]ppG in any of the experiments, and there was no detectable effect on the potency of OTA to displace the tracer or on the number of receptor sites as deduced from Scatchard plots (results not shown). Finally, it should be added that the effect of p[NH]ppG was variable between various batches of membrane preparation; the maximal right-shift of the OT curve was 2-fold. This is possibly due to the presence of variable amounts of endogenous GDP and/or G-proteins in different batches of membrane preparation.
The activity of various types of G-proteins is destroyed by alkylation with N-ethylmaleimide (cf. [20] ). Treatment of the membrane preparation for 30 min at 37°C with this reagent at 1 mmol/l had no appreciable effect on the binding of 125I-OTA or on the potency of OT to displace 125I-OTA (results not shown).
In summary, the effects of manipulating G-protein function in this system are minimal compared with the changes brought about by altering the concentration of Mg2+. Taken together, these observations support the notion [2] that Mg2+ interacts with the ligand-binding site of the OT receptor to stabilize a conformation favouring high affinity and specific binding of agonists. Given a number of analogous observations with V1-and V3-type receptors for vasopressin, it appears that the requirement for Mg2+ is a generic mechanism for ligand recognition by these receptors. Further studies with purified receptor and G-protein preparations are required to establish this hypothesis.
